Investopedia: The Week Ahead In Healthcare

Earnings season is now winding down and very little has changed in the healthcare sector. Hospitals in the U.S. are still being cautious with their capital spending, while European health systems are pushing back hard on prices for both devices and drugs. Companies with differentiated products are doing well (Abbott Labs' (NYSE:ABT) Humira, Edwards Lifesciences' (NYSE:EW) transcatheter heart valve), Intuitive Surgical's (Nasdaq:ISRG) DaVinci surgical robot and tools), but general trends seem more like "muddle through" right now.

Please click here for more:
http://stocks.investopedia.com/stock-analysis/2012/The-Week-Ahead-In-Healthcare-AMRN-REGN-EW-ISRG0727.aspx